What insurance policy changes affect HCPCS A4239?

There are 8 tracked policy changes affecting HCPCS A4239, including updates from UnitedHealthcare, Excellus BlueCross BlueShield, Health Net. Each change may modify coverage criteria, reimbursement rates, or prior-authorization requirements.

Which payers have updated policy for HCPCS A4239?

Payers that have issued tracked updates for HCPCS A4239 include: UnitedHealthcare, Excellus BlueCross BlueShield, Health Net, Connecticut Medicaid (HUSKY Health).

How do I get notified when HCPCS A4239 policy changes?

Create a free account at PolicyChanges.app and save a search filtered to HCPCS A4239. You will receive a daily digest email whenever a new policy change references this code.

Why do payers change policies for HCPCS A4239?

Payers revise policies for individual billing codes to align with updated clinical guidelines, CMS rule changes, fraud and abuse prevention measures, or network cost-management goals. Changes can affect medical necessity criteria, place-of-service restrictions, bundling rules, or whether a code requires prior authorization.

A4239 — Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service: Insurance Policy Changes

A4239 Insurance Policy Changes

HCPCS A4239 is officially defined as "Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service." HCPCS A4239 is referenced in 8 tracked payer policy changes from UnitedHealthcare, Excellus BlueCross BlueShield, and 2 other payers. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS A4239 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

High impact

Continuous Glucose Monitoring Systems/External Insulin Pump Therapy for Diabetes 1.01.30

Excellus BlueCross BlueShield·Effective Jan 1, 2026

Excellus BlueCross BlueShield updated their comprehensive policy for continuous glucose monitoring systems and external insulin pump therapy for diabetes, establishing detailed coverage criteria for initial requests, replacements, and artificial pancreas systems. The policy includes specific requirements for multiple daily injections, glucose testing frequency, and diabetes education completion.

A4239 Insurance Policy Changes

Idaho Medicaid: New billing updates for diabetes equipment and supplies

Continuous Glucose Monitoring Systems/External Insulin Pump Therapy for Diabetes 1.01.30

25-997 Streamlining Prior Authorization: Simplifying Processes for Better Efficiency

25-998 Streamlining Prior Authorization: Simplifying Processes for Better Efficiency

Idaho Medicaid: New billing updates for diabetes equipment and supplies

25-996 Streamlining Prior Authorization: Simplifying Processes for Better Efficiency

25-999 Streamlining Prior Authorization: Simplifying Processes for Better Efficiency

2025.39 - Provider Bulletin - Revised Billing Guidelines for CGMs & Adjunctive Non-Implanted CGMs